{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:48:35Z","timestamp":1782110915997,"version":"3.54.5"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Cadherin-3 (CDH3), which encodes P-cadherin, is a classical cadherin involved in epithelial architecture, basal-cell identity, and tissue repair. Once viewed primarily as a structural adhesion molecule, CDH3 is now recognized as a context-dependent regulator of tumor progression and a candidate therapeutic target across several human malignancies. Available evidence indicates that CDH3 is frequently overexpressed in breast, lung, gastric, colorectal, pancreatic, biliary, ovarian, and glioblastoma settings, where it is commonly linked to high grade, invasion, metastasis, therapy resistance, and unfavorable outcomes. A unidirectional interpretation is nevertheless insufficient. In melanoma, bladder carcinoma, hepatocellular carcinoma, renal cancer, and selected lineage-specific settings, CDH3 loss, cytoplasmic redistribution, or restoration can instead associate with altered adhesion control, reduced invasion, or bidirectional phenotypes. Mechanistically, CDH3 operates at the intersection of cell-cell adhesion and signaling output. Its dysregulation is shaped by promoter methylation, chromatin remodeling, transcription-factor programs, noncoding RNAs, oxidative stress, and protein-stability pathways. Functionally, CDH3 can amplify epidermal growth factor receptor and insulin-like growth factor 1 receptor signaling, cooperate with Wnt and Rho GTPase circuits, organize collective migration and extracellular-matrix remodeling, support stem-like and metabolic states, and integrate hypoxia- or exosome-driven communication. Translationally, CDH3 has progressed from a tumor-associated antigen to a platform for monoclonal antibodies, antibody-drug conjugates, bispecific T-cell engagers, radioimmunotherapy, and apoptosis-inducing bispecific constructs. Clinical implementation remains constrained by expression heterogeneity, normal-tissue expression, and the lack of robust companion diagnostics. Clarifying its lineage dependence, membrane-functional state, and biomarker-guided therapeutic window will be essential for converting promising biological knowledge into clinically useful diagnostics and treatments.<\/jats:p>","DOI":"10.3389\/fphar.2026.1874056","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:18:52Z","timestamp":1782109132000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["CDH3 in human tumors: tumor biology and potential therapeutic target"],"prefix":"10.3389","volume":"17","author":[{"given":"Xu-Sheng","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, The Second Affiliated Hospital of Soochow University","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Jun","family":"Pei","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Second Affiliated Hospital of Soochow University","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1093\/hmg\/ddq134","article-title":"ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C\/EBP in CDH3 gene activation","volume":"19","author":"Albergaria","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1387\/ijdb.113382aa","article-title":"P-cadherin role in normal breast development and cancer","volume":"55","author":"Albergaria","year":"2011","journal-title":"Int. J. Dev. Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e55749","DOI":"10.1371\/journal.pone.0055749","article-title":"CCAAT\/enhancer binding protein \u03b2 (C\/EBP\u03b2) isoforms as transcriptional regulators of the pro-invasive CDH3\/P-Cadherin gene in human breast cancer cells","volume":"8","author":"Albergaria","year":"2013","journal-title":"PLoS ONE"},{"key":"B4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.5115\/acb.2010.43.2.110","article-title":"CDH3\/P-Cadherin regulates migration of HuCCT1 cholangiocarcinoma cells","volume":"43","author":"Baek","year":"2010","journal-title":"Anat. Cell Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/carcin\/bgr059","article-title":"Slit-2 facilitates interaction of P-cadherin with Robo-3 and inhibits cell migration in an oral squamous cell carcinoma cell line","volume":"32","author":"Bauer","year":"2011","journal-title":"Carcinogenesis"},{"key":"B6","first-page":"6125","article-title":"Downregulation of P-cadherin expression in hepatocellular carcinoma induces tumorigenicity","volume":"7","author":"Bauer","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00428-025-04104-7","article-title":"P-cadherin overexpression is associated with early transformation of the Fallopian tube epithelium and aggressiveness of tubo-ovarian high-grade serous carcinoma","volume":"488","author":"Can\u00e1rio","year":"2025","journal-title":"Virchows Arch."},{"key":"B8","doi-asserted-by":"publisher","first-page":"116362","DOI":"10.1016\/j.celrep.2025.116362","article-title":"CDH3-AS1 antisense RNA enhances P-cadherin translation and acts as a tumor suppressor in melanoma","volume":"44","author":"Chadourne","year":"2025","journal-title":"Cell Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1038\/s41379-020-0591-3","article-title":"E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements","volume":"33","author":"Christgen","year":"2020","journal-title":"Mod. Pathol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1158\/1535-7163.MCT-21-0652","article-title":"A First-in-Human, phase I, multicenter, open-label, dose-escalation study of PCA062: an antibody\u2013drug conjugate targeting P-Cadherin, in patients with solid tumors","volume":"21","author":"Duca","year":"2022","journal-title":"Mol. Cancer Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3892\/ol.2021.12755","article-title":"MicroRNA-665 regulates the proliferation, apoptosis and adhesion of gastric cancer cells by binding to cadherin 3","volume":"21","author":"Fang","year":"2021","journal-title":"Oncol. Lett."},{"key":"B12","doi-asserted-by":"publisher","first-page":"16476","DOI":"10.3390\/ijms242216476","article-title":"Alteration of cadherin 3 expression and DNA methylation in association with aggressive renal cell carcinoma","volume":"24","author":"Faraj Tabrizi","year":"2023","journal-title":"IJMS"},{"key":"B13","doi-asserted-by":"publisher","first-page":"dmm049652","DOI":"10.1242\/dmm.049652","article-title":"Activation of an actin signaling pathway in pre-malignant mammary epithelial cells by P-cadherin is essential for transformation","volume":"16","author":"Faria","year":"2023","journal-title":"Dis. Model. Mech."},{"key":"B14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00428-018-2406-1","article-title":"Differential expression of E-cadherin and P-cadherin in pT3 prostate cancer: correlation with clinical and pathological features","volume":"473","author":"Ferreira","year":"2018","journal-title":"Virchows Arch."},{"key":"B15","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1186\/s12885-025-13845-2","article-title":"Synergistic potential of CDH3 in targeting CRC metastasis and enhancing immunotherapy","volume":"25","author":"Fu","year":"2025","journal-title":"BMC Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"232","DOI":"10.2967\/jnumed.120.245837","article-title":"Preclinical characterization of the Radioimmunoconjugate111 in or90 Y-FF-21101 against a P-Cadherin\u2013Expressing tumor in a mouse xenograft model and a nonhuman primate","volume":"62","author":"Funase","year":"2021","journal-title":"J. Nucl. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1186\/s12967-025-06750-6","article-title":"CDH3 promotes the progression of lung adenocarcinoma through driving epithelial-mesenchymal transition progress","volume":"23","author":"Gong","year":"2025","journal-title":"J. Transl. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s10549-009-0565-0","article-title":"BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer","volume":"122","author":"Gorski","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e12361","DOI":"10.1002\/2056-4538.12361","article-title":"Microenvironment-induced restoration of cohesive growth associated with focal activation of P-cadherin expression in lobular breast carcinoma metastatic to the Colon","volume":"10","author":"Gronewold","year":"2024","journal-title":"J. Pathol. Clin. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.17305\/bb.2024.10944","article-title":"Hsa_circ_0023179 modulated the processes of proliferation, apoptosis, and EMT in non-small cell lung cancer cells via the miR-615-5p\/CDH3 axis","volume":"25","author":"Guo","year":"2024","journal-title":"Biomol. Biomed."},{"key":"B21","doi-asserted-by":"publisher","first-page":"845417","DOI":"10.3389\/fimmu.2022.845417","article-title":"A phase 1 dose-escalation study of PF-06671008, a bispecific T-Cell-Engaging therapy targeting P-Cadherin in patients with advanced solid tumors","volume":"13","author":"Harding","year":"2022","journal-title":"Front. Immunol."},{"key":"B22","first-page":"3945","article-title":"Frequent CDH3 demethylation in advanced gastric carcinoma","volume":"29","author":"Hibi","year":"2009","journal-title":"Anticancer Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1158\/1078-0432.CCR-19-3972","article-title":"Integrative omics analysis reveals soluble Cadherin-3 as a survival predictor and an early monitoring marker of EGFR tyrosine kinase inhibitor therapy in lung cancer","volume":"26","author":"Hsiao","year":"2020","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.devcel.2022.12.005","article-title":"A Cdh3-\u03b2-catenin-laminin signaling axis in a subset of breast tumor leader cells control leader cell polarization and directional collective migration","volume":"58","author":"Hwang","year":"2023","journal-title":"Dev. Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"6487","DOI":"10.1158\/1078-0432.CCR-08-1086","article-title":"Identification of a novel tumor-associated antigen, cadherin 3\/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers","volume":"14","author":"Imai","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.lungcan.2018.01.018","article-title":"High expression of P-cadherin is significantly associated with poor prognosis in patients with non-small-cell lung cancer","volume":"118","author":"Imai","year":"2018","journal-title":"Lung Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/1476-4598-9-255","article-title":"P-cadherin counteracts myosin II-B function: implications in melanoma progression","volume":"9","author":"Jacobs","year":"2010","journal-title":"Mol. Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/CEJ.0b013e3283429e8b","article-title":"P-cadherin expression reduces melanoma growth, invasion, and responsiveness to growth factors in nude mice","volume":"20","author":"Jacobs","year":"2011","journal-title":"Eur. J. Cancer Prev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2438173","DOI":"10.1080\/19420862.2024.2438173","article-title":"A TRAILR2\/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer","volume":"16","author":"Jung","year":"2024","journal-title":"mAbs"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e4132","DOI":"10.1097\/MD.0000000000004132","article-title":"mRNA expression of CDH3, IGF2BP3, and BIRC5 in biliary brush cytology specimens is a useful adjunctive tool of cytology for the diagnosis of malignant biliary stricture","volume":"95","author":"Kim","year":"2016","journal-title":"Med. Baltim."},{"key":"B31","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1476-4598-13-170","article-title":"HOXA9 promotes homotypic and heterotypic cell interactions that facilitate ovarian cancer dissemination via its induction of P-cadherin","volume":"13","author":"Ko","year":"2014","journal-title":"Mol. Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1039\/c2mb25161b","article-title":"Structural and thermodynamic characterization of the self-adhesive properties of human P-cadherin","volume":"8","author":"Kudo","year":"2012","journal-title":"Mol. Biosyst."},{"key":"B33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.18632\/oncoscience.370","article-title":"P-Cadherin (CDH3) is overexpressed in colorectal tumors and has potential as a serum marker for colorectal cancer monitoring","volume":"4","author":"Kumara","year":"2017","journal-title":"Oncoscience"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e11801","DOI":"10.1371\/journal.pone.0011801","article-title":"p120ctn and P-cadherin but not E-cadherin regulate cell motility and invasion of DU145 prostate cancer cells","volume":"5","author":"K\u00fcmper","year":"2010","journal-title":"PLoS One"},{"key":"B35","doi-asserted-by":"publisher","first-page":"jcs233189","DOI":"10.1242\/jcs.233189","article-title":"P-cadherin-induced decorin secretion is required for collagen fiber alignment and directional collective cell migration","volume":"132","author":"Le Borgne-Rochet","year":"2019","journal-title":"J. Cell Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7150\/ijbs.30857","article-title":"KLF4-Mediated CDH3 upregulation suppresses human hepatoma cell growth and migration via GSK-3\u03b2 signaling","volume":"15","author":"Li","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/mc.23126","article-title":"Long noncoding RNA ADAMTS9AS2 suppresses the progression of esophageal cancer by mediating CDH3 promoter methylation","volume":"59","author":"Liu","year":"2020","journal-title":"Mol. Carcinog."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s13402-025-01061-w","article-title":"Dual blockage of P-cadherin and c-Met synergistically inhibits the growth of head and neck cancer","volume":"48","author":"Liu","year":"2025","journal-title":"Cell Oncol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"100058","DOI":"10.1016\/j.nbe.2026.100058","article-title":"Engineering a robust wnt-related diagnostic model for lung adenocarcinoma via machine learning algorithms and multi-cohort validation","volume":"18","author":"Liu","year":"2026","journal-title":"Nano Biomed. Eng."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.3892\/or.2014.3545","article-title":"P-cadherin potentiates ligand-dependent EGFR and IGF-1R signaling in dysplastic and malignant oral keratinocytes","volume":"32","author":"Lysne","year":"2014","journal-title":"Oncol. Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s13258-023-01476-5","article-title":"Downregulated CDH3 is correlated with a better prognosis for LUAD and decreases proliferation and migration of lung cancer cells","volume":"46","author":"Ma","year":"2024","journal-title":"Genes. Genom"},{"key":"B42","doi-asserted-by":"publisher","first-page":"115096","DOI":"10.1016\/j.celrep.2024.115096","article-title":"P-cadherin mechanoactivates tumor-mesothelium metabolic coupling to promote ovarian cancer metastasis","volume":"44","author":"Ma","year":"","journal-title":"Cell Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3390\/antiox14030332","article-title":"Oxidative stress regulates CDH3 expression in lung cancer cells via OGG1-Mediated SP1 binding","volume":"14","author":"Ma","year":"","journal-title":"Antioxidants"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1111\/j.1464-410X.2008.08115.x","article-title":"P-cadherin as a prognostic indicator and a modulator of migratory behaviour in bladder carcinoma cells","volume":"102","author":"Mandeville","year":"2008","journal-title":"BJU Int."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1002\/1878-0261.13162","article-title":"Cadherin3 is a novel oncogenic biomarker with prognostic value in glioblastoma","volume":"16","author":"Martins","year":"2022","journal-title":"Mol. Oncol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1158\/1078-0432.CCR-05-0059","article-title":"P-Cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation","volume":"11","author":"Paredes","year":"2005","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1007\/s10637-011-9710-9","article-title":"Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer","volume":"30","author":"Park","year":"2012","journal-title":"Invest. New Drugs"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.3390\/pharmaceutics17111442","article-title":"The aptamer bi-(AID-1-T) synergizes with radiation to inhibit proliferation of human glioma cells","volume":"17","author":"Pavlova","year":"2025","journal-title":"Pharmaceutics"},{"key":"B49","doi-asserted-by":"publisher","first-page":"6373","DOI":"10.1111\/jcmm.16615","article-title":"Transcriptome and DNA methylation analysis reveals molecular mechanisms underlying intrahepatic cholangiocarcinoma progression","volume":"25","author":"Peng","year":"2021","journal-title":"J. Cell. Mol. Medi"},{"key":"B50","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1080\/21541248.2016.1173772","article-title":"P-cadherin-mediated rho GTPase regulation during collective cell migration","volume":"7","author":"Plutoni","year":"","journal-title":"Small GTPases"},{"key":"B51","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1083\/jcb.201505105","article-title":"P-cadherin promotes collective cell migration via a Cdc42-mediated increase in mechanical forces","volume":"212","author":"Plutoni","year":"","journal-title":"J. Cell Biol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e893","DOI":"10.1136\/bmjspcare-2020-002204","article-title":"Breast cancer prognosis and P-cadherin expression: systematic review and study-level meta-analysis","volume":"12","author":"Qi","year":"2022","journal-title":"BMJ Support Palliat. Care"},{"key":"B53","doi-asserted-by":"publisher","first-page":"103040","DOI":"10.1016\/j.tice.2025.103040","article-title":"USP8-mediated CDH3 drives the malignant progression of lung adenocarcinoma by regulating ferroptosis","volume":"97","author":"Qv","year":"2025","journal-title":"Tissue Cell"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.3390\/cancers15184532","article-title":"Dosimetry of a novel 111Indium-Labeled Anti-P-Cadherin monoclonal antibody (FF-21101) in non-human Primates","volume":"15","author":"Ravizzini","year":"2023","journal-title":"Cancers"},{"key":"B55","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/path.4143","article-title":"P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model","volume":"229","author":"Ribeiro","year":"2013","journal-title":"J. Pathol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12964-018-0286-2","article-title":"SRC inhibition prevents P-cadherin mediated signaling and function in basal-like breast cancer cells","volume":"16","author":"Ribeiro","year":"2018","journal-title":"Cell Commun. Signal"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.humpath.2009.12.016","article-title":"Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract","volume":"41","author":"Riener","year":"2010","journal-title":"Hum. Pathol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/antib5010006","article-title":"Development of PF-06671008, a highly potent Anti-P-cadherin\/Anti-CD3 bispecific DART molecule with extended half-life for the treatment of cancer","volume":"5","author":"Root","year":"2016","journal-title":"Antibodies (Basel)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"6835","DOI":"10.18632\/oncotarget.6899","article-title":"Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer","volume":"7","author":"Royo","year":"2016","journal-title":"Oncotarget"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/cas.12732","article-title":"Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer","volume":"106","author":"Sakamoto","year":"2015","journal-title":"Cancer Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"149594","DOI":"10.1016\/j.gene.2025.149594","article-title":"Transcriptomic profiling and bioinformatics-driven statistical prioritization of CRC biomarkers: a step toward precision oncology","volume":"964","author":"Saleh","year":"2025","journal-title":"Gene"},{"key":"B62","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3390\/biology12060803","article-title":"3D chromatin architecture Re-Wiring at the CDH3\/CDH1 loci contributes to E-Cadherin to P-Cadherin expression switch in gastric cancer","volume":"12","author":"S\u00e3o Jos\u00e9","year":"2023","journal-title":"Biology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"881","DOI":"10.7150\/jca.82916","article-title":"MicroRNA 133A regulates cell proliferation, cell migration, and apoptosis in colorectal cancer by suppressing CDH3 expression","volume":"14","author":"Sharma","year":"2023","journal-title":"J. Cancer"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1158\/1535-7163.MCT-20-0708","article-title":"PCA062, a P-cadherin targeting antibody\u2013drug conjugate, displays potent antitumor activity against P-cadherin\u2013expressing malignancies","volume":"20","author":"Sheng","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"B65","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/bjc.2017.411","article-title":"Cadherin-1 and cadherin-3 cooperation determines the aggressiveness of pancreatic ductal adenocarcinoma","volume":"118","author":"Siret","year":"2018","journal-title":"Br. J. Cancer"},{"key":"B66","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.7150\/jca.98337","article-title":"CDH3 is an effective serum biomarker of colorectal cancer distant metastasis patients","volume":"15","author":"Song","year":"2024","journal-title":"J. Cancer"},{"key":"B67","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1186\/1471-2407-14-734","article-title":"The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype","volume":"14","author":"Sousa","year":"2014","journal-title":"BMC Cancer"},{"key":"B68","doi-asserted-by":"publisher","first-page":"165964","DOI":"10.1016\/j.bbadis.2020.165964","article-title":"P-cadherin induces anoikis-resistance of matrix-detached breast cancer cells by promoting pentose phosphate pathway and decreasing oxidative stress","volume":"1866","author":"Sousa","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B69","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10549-019-05477-5","article-title":"Increased expression of P-cadherin is an indicator of poor prognosis in breast cancer: a systematic review and meta-analysis","volume":"179","author":"Sridhar","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"B70","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.1158\/1078-0432.CCR-20-0037","article-title":"Phase I study of P-cadherin-targeted radioimmunotherapy with 90Y-FF-21101 monoclonal antibody in solid tumors","volume":"26","author":"Subbiah","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ajpath.2011.03.046","article-title":"P-cadherin promotes liver metastasis and is associated with poor prognosis in Colon cancer","volume":"179","author":"Sun","year":"2011","journal-title":"Am. J. Pathol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/modpathol.2010.189","article-title":"P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer","volume":"24","author":"Turashvili","year":"2011","journal-title":"Mod. Pathol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1158\/1541-7786.MCR-13-0489","article-title":"P-cadherin promotes ovarian cancer dissemination through tumor cell aggregation and tumor-peritoneum interactions","volume":"12","author":"Usui","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"8774","DOI":"10.1158\/0008-5472.CAN-04-4414","article-title":"P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma","volume":"65","author":"Van Marck","year":"2005","journal-title":"Cancer Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/ijc.25427","article-title":"P-cadherin in adhesion and invasion: opposite roles in Colon and bladder carcinoma","volume":"128","author":"Van Marck","year":"2011","journal-title":"Int. J. Cancer"},{"key":"B76","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/stem.1075","article-title":"P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer","volume":"30","author":"Vieira","year":"2012","journal-title":"Stem Cells"},{"key":"B77","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1007\/s00405-021-07181-x","article-title":"Placental-cadherin, a biomarker for local immune status and poor prognosis among patients with tongue squamous cell carcinoma","volume":"279","author":"Wang","year":"2022","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"6535","DOI":"10.1093\/nar\/gkn697","article-title":"Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer","volume":"36","author":"Xi","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s13577-025-01261-4","article-title":"Exosomal FGD5-AS1 promotes proliferation of lung cancer cells under hypoxia by inhibiting miR-1179 and activating P-cadherin","volume":"38","author":"Yang","year":"","journal-title":"Hum. Cell"},{"key":"B80","doi-asserted-by":"publisher","first-page":"e19785","DOI":"10.7717\/peerj.19785","article-title":"Prognostic role and functional impact of cadherin genes in non-small cell lung cancer tumorigenesis: mechanistic insights from in silico and in vitro analyses","volume":"13","author":"Yang","year":"","journal-title":"PeerJ"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00262-011-1186-0","article-title":"In vivo therapeutic effect of CDH3\/P-cadherin-targeting radioimmunotherapy","volume":"61","author":"Yoshioka","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"B82","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.1158\/1078-0432.CCR-10-1343","article-title":"PF-03732010: a fully human monoclonal antibody against P-cadherin with antitumor and antimetastatic activity","volume":"16","author":"Zhang","year":"2010","journal-title":"Clin. Cancer Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1874056\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:18:53Z","timestamp":1782109133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1874056\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":82,"alternative-id":["10.3389\/fphar.2026.1874056"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1874056","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"article-number":"1874056"}}